Immunosenescence and stem cell metabolism


Our focus

We are focussed on identifying the metabolic pathways regulating hematopoietic stem and immune cells function. Our goal is to develop targeted metabolic therapies capable of preserving hematopoietic stem and immune cell functions in the context of aging and chemotherapeutic treatments.


Our projects

Metabolic reprogramming of aged hematopoetic stem and immune cells

Aging is associated with the decline of immune function, especially T-cell mediated activity, which contributes to a reduced tumor immunosurveillance and thus increased tumor insurgences with age. Lymphoid progenitor cells are formed in the bone marrow from hematopoietic stem cells (HSCs) and aging processes profoundly perturb HSCs function. Aging primes HSCs toward myeloid lineages and thus reduces the lymphoid compartment and compromises immune-reconstitution and immunosurveillance.

Over the past years, metabolism has been emerging as major regulator of stem and immune cells function and activation. Recently, it has been shown that metabolic interventions both in animal model and in human can profoundly alter stem and immune cell function. In light of this, we are interested in identifying the metabolic changes happening in HSCs and immune system during aging and developping targeted metabolic therapies in order to re-program stem and immune function in the elderly. 

Vannini 1.jpg

Metabolic prevention of chemotherapy-induced immunosuppression

Chemotherapy results in substantial damage to the immune system by affecting the hematopoietic stem and progenitor cells (HSPCs) function, leading to myeloid bias differentiation and subsequent immunosuppression. We are interested in understanding the metabolic changes occuring upon chemotherapy in HSPCs and T cells and developping metabolic/nutritional strategies capable of preserving stem and immune cell functions. 

Vannini 2.jpg

NAD metabolism in immune cells

NAD precursor nicotinamide riboside (NR) has been shown to protect against high fat diet-induced obesity and extend lifespan. Interestingly, in our previous studies we demonstrated that NR is capable to expand HSPCs and lymphoid compartments in vivo  (Vannini et al., Under revision) Following up this earlier research, our goal now is to understand the role of NAD metabolism in immune cells.  

Vannini 3.jpg

Vannini 4.jpg



UNIL web teasers general.png


News @Vannini Lab

From Bench to Business: NADUP Secures InnoTREK Grant for Transformative Start-up Journey 

From Bench to Business: NADUP Secures InnoTREK Grant for Transformative Start-up Journey 

News @Vannini Lab

Urolithine-A : Une Nouvelle Frontière dans la Défense contre le Cancer

Urolithine-A : Une Nouvelle Frontière dans la Défense contre le Cancer

Follow us:  




Department of oncology UNIL CHUV
Ludwig Institute for Cancer Research Lausanne

Ludwig Lausanne RGB-crop461x374.jpg (Print)

Phone +41 21 692 59 34



WEB medallions 150 x100-1 unsplash alexander shatov.png

Ch. des Boveresses 155 - CH-1066 Epalinges
Tel. +41 21 692 59 92
Fax +41 21 692 59 95
Ludwig Cancer ResearchUniversité de LausanneCentre Hospitalier Universitaire Vaudois (CHUV)